(Q31013349)

28 June 2017

1 reference

title

Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma (English)

1 reference

28 June 2017

1 reference

Sivak-Callcott JA

1

1 reference

28 June 2017

O'Day DM

series ordinal

2

1 reference

28 June 2017

Gass JD

series ordinal

3

1 reference

28 June 2017

Tsai JC

series ordinal

4

1 reference

28 June 2017

language of work or name

1 reference

1 October 2001

1 reference

28 June 2017

1 reference

28 June 2017

108

1 reference

28 June 2017

10

1 reference

28 June 2017

1767-76; quiz1777, 1800

1 reference

Neovascular glaucoma. Etiologic considerations.

28 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Long-Term Results of Valve Implants in Filtering Surgery for Eyes with Neovascular Glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Evidence-based analysis of prophylactic treatment of asymptomatic retinal breaks and lattice degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Factors controlling ocular angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Vascular Endothelial Growth Factor Level in Aqueous Humor of Diabetic Patients With Rubeotic Glaucoma Is Markedly Elevated

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Neovascular glaucoma and vitreous hemorrhage following cataract surgery in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

The Effect of Lensectomy on the Incidence of Iris Neovascularization and Neovascular Glaucoma After Vitrectomy for Diabetic Retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Neovascular glaucoma following neodymium-YAG laser posterior capsulotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

The Myofibroblastic Component of Rubeosis Iridis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

The association of rubeosis iridis with endothelialisation of the anterior chamber: report of a clinical case with histopathological review of 16 additional cases

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Clinical and infrared pupillometry in central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

The risk of missing angle neovascularization by omitting screening gonioscopy in acute central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Diabetic iris neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Fluorescein gonioangiography in diabetic neovascularisation.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Infrared angiography of the anterior ocular segment

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Cone b-wave implicit time as an early predictor of rubeosis in central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Electroretinogram parameters at presentation as predictors of rubeosis in central retinal vein occlusion patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Early electroretinography in unilateral central retinal vein occlusion as a predictor of rubeosis iridis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

The effect of pan-retinal photo-coagulation on rubeosis iridis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Regression of Iris Neovascularization Following Panretinal Photocoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Effects of argon laser photocoagulation on rubeosis iridis and angle neovascularization.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

A prospective follow-up study of panretinal photocoagulation in preventing neovascular glaucoma following ischaemic central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Diabetic Rubeosis and Panretinal Photocoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Efficacy of panretinal photocoagulation in preventing neovascular glaucoma following ischemic central retinal vein obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Comparison between efficacy of full- and mild-scatter (panretinal) photocoagulation on the course of diabetic rubeosis iridis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Filtration Surgery in the Treatment of Neovascular Glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

1 reference

7 January 2021

Diabetic iris neovascularization. Natural history and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Panretinal cryopexy for the management of neovascularization of the iris

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Role of anterior retinal cryoablation in the management of neovascular glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Panretinal cryotherapy in neovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Initial clinical experience using a diode laser in the treatment of retinal vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Combined transscleral diode laser cyclophotocoagulation and transscleral retinal photocoagulation for refractory neovascular glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Peripheral transscleral retinal diode laser for rubeosis iridis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

"Cyclodiode". Trans-scleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Tube-shunt surgery versus neodymium:YAG cyclophotocoagulation in the management of neovascular glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

High incidence of sympathetic ophthalmia after contact and noncontact neodymium:YAG cyclotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Surgical intervention on the ciliary body; new trends for the relief of glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Rubeosis iridis and neovascular glaucoma. Evaluation of cyclocryotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Cyclocryotherapy in the treatment of advanced glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

5-Fluorouracil filtering surgery and neovascular glaucoma. Long-term follow-up of the original pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Combined Molteno implantation and pars plana vitrectomy for neovascular glaucomas

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Carbon Dioxide Laser Trabeculostomy for the Treatment of Neovascular Glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

The visual outcome in cases of neovascular glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

Combined pars plana vitrectomy and glaucoma drainage implant placement for refractory glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900775-8

7 January 2021

10.1016/S0161-6420(01)00775-8

Identifiers

DOI

1 reference

28 June 2017

1 reference